Many In Primary Care Want Patients  To Share Mental Health Concerns

Michele Long, CNP, reviews the results of the GeneSight test with her patient, Beth. With a simple cheek swab, the test provides clinicians with a patient’s unique genetic information that indicates which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects.

Don't miss the big stories. Like us on Facebook.  

(NAPSI)—Nurse practitioner Michele Long has been Beth’s primary care provider for years. So, when Beth started experiencing symptoms of depression, she scheduled an appointment with Michele. 



It was the right decision. According to Beth, “Michele made me feel very comfortable talking to her about my mental health.”

Talking about mental health with primary care providers is something doctors and nurse practitioners want more people to do. According to the GeneSight Mental Health Monitor national survey from Myriad Genetics, more than 83 percent of primary care providers (PCPs) wish more of their patients would tell them about their mental health concerns. 



Yet, more than half of surveyed clinicians don’t think patients are aware that PCPs and nurse practitioners are fully trained to diagnose and treat mental health conditions. 



“It would be great if patients knew that they could bring up their mental health concerns to me,” said Long. “But it is also my responsibility to complete depression and anxiety screening with them.” 



Support our journalism. Subscribe today. →

Regular mental health screenings at primary care appointments are a good first step in addressing patients’ mental health, bridging the communication gap, and accurately diagnosing those suffering with mental health conditions. However, diagnosis is just the beginning of what is often an uphill battle to find the appropriate medication and dosage to alleviate patients’ symptoms. 



One tool that may help providers is the GeneSight test, which is a genetic test that determines how your genes may affect medication outcomes. Providers get a report about which medications to treat depression, anxiety, ADHD, and other mental health conditions may require dose adjustments, be less likely to work, or have an increased risk of side effects based on a patient’s DNA. 



Long uses the GeneSight test to help reduce the medication trial-and-error process. After seeing that a prior depression medication didn’t work for Beth, Long ordered the GeneSight test and used the information to decide how to change Beth’s prescription. Today, Beth says she “feels so much better” and more like herself.



“Finding effective treatment can be a very frustrating process for patients. They often feel defeated when a medication doesn’t help them,” Long said. “GeneSight is a valuable tool that helps me find solutions for patients who have entrusted me with caring for their mental health.”



For more information about genetic testing and mental health, ask your clinician or visit


If you'd like to leave a comment (or a tip or a question) about this story with the editors, please email us.
We also welcome letters to the editor for publication; you can do that by filling out our letters form and submitting it to the newsroom.